PDS Biotechnology
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell PDSB and other ETFs, options, and stocks.About PDSB
PDS Biotechnology Corp. engages in the development of clinical-stage immunotherapies to treat various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its product, PDS0101, is an off the shelf immunotherapeutic that is administered by subcutaneous injection.
CEOFrank K. Bedu-Addo
CEOFrank K. Bedu-Addo
Employees24
Employees24
HeadquartersPrinceton, New Jersey
HeadquartersPrinceton, New Jersey
Founded2005
Founded2005
Employees24
Employees24
PDSB Key Statistics
Market cap47.83M
Market cap47.83M
Price-Earnings ratio-1.10
Price-Earnings ratio-1.10
Dividend yield—
Dividend yield—
Average volume715.31K
Average volume715.31K
High today$0.93
High today$0.93
Low today$0.8627
Low today$0.8627
Open price$0.8975
Open price$0.8975
Volume316.92K
Volume316.92K
52 Week high$2.20
52 Week high$2.20
52 Week low$0.703
52 Week low$0.703
Stock Snapshot
As of today, PDS Biotechnology(PDSB) shares are valued at $0.88. The company's market cap stands at 47.83M, with a P/E ratio of -1.10.
During the trading session on 2025-12-17, PDS Biotechnology(PDSB) shares reached a daily high of $0.93 and a low of $0.86. At a current price of $0.88, the stock is +2.4% higher than the low and still -5.0% under the high.
Trading volume for PDS Biotechnology(PDSB) stock has reached 316.92K, versus its average volume of 715.31K.
Over the past 52 weeks, PDS Biotechnology(PDSB) stock has traded between a high of $2.20 and a low of $0.70.
Over the past 52 weeks, PDS Biotechnology(PDSB) stock has traded between a high of $2.20 and a low of $0.70.
People also own
Based on the portfolios of people who own PDSB. This list is generated using Robinhood data, and it’s not a recommendation.